Investigation of the Effects of Serratus Posterior Superior Intercostal Plane Block and Serratus Anterior Plane Block on Perioperative Analgesia Management in Patients Scheduled for Mastectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorUludag University

About this trial

This study aims to evaluate and compare the analgesic efficacy of two ultrasound-guided regional anesthesia techniques, the serratus anterior plane (SAP) block and the serratus posterior superior intercostal plane (SPSIP) block, in patients undergoing elective mastectomy surgery. Postoperative pain following mastectomy is a common and significant clinical problem that negatively affects patient comfort, delays mobilization, and may prolong hospital stay. Although systemic analgesics are commonly used, they are associated with adverse effects such as sedation, constipation, and potential dependency.

In this randomized clinical study, female patients aged 18-75 years with ASA physical status I-III scheduled for elective mastectomy will be included after obtaining informed consent. Patients will be allocated into two groups to receive either SAP block or SPSIP block under ultrasound guidance prior to surgery. Standardized general anesthesia and perioperative analgesia protocols will be applied to all patients.

The primary objective is to compare postoperative pain scores between the two groups using the Numeric Rating Scale (NRS). Secondary outcomes include time to first analgesic requirement, total analgesic consumption, intraoperative opioid use, and hemodynamic parameters. By comparing these two interfascial plane blocks, this study aims to identify a more effective analgesic technique that improves postoperative pain control, enhances patient comfort, and facilitates early mobilization following mastectomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female patients aged between 18 and 75 years

Patients scheduled for elective mastectomy surgery

American Society of Anesthesiologists (ASA) physical status I-III

Patients who provide written informed consent

Disqualifiers

Patients who refuse to participate in the study

Patients with American Society of Anesthesiologists (ASA) physical status IV or V

Patients receiving anticoagulant therapy or with suspected coagulopathy

Patients with known allergy to local anesthetic agents

Trial design

Design model

Parallel

Treatments tested in this trial

  • SAP Block

    Procedure/Surgery

    Under ultrasound guidance with a linear probe, the needle is inserted along the posterior axillary line between the second and seventh ribs and advanced into the plane between the serratus anterior muscle and the rib surface. A total of 30 mL of 0.25% bupivacaine (maximum dose 2 mg/kg/day) is injected.

  • SPSIP Block

    Procedure/Surgery

    Under ultrasound guidance with a linear probe, the superomedial border of the scapula on the operative side is identified. The needle is inserted medial to the scapula between the second and seventh ribs and advanced into the interfascial plane between the serratus posterior superior muscle and the intercostal muscles. Subsequently, 30 mL of 0.25% bupivacaine (maximum dose 2 mg/kg/day) is administered.

Treatment groups

66 Participants
are divided into 2 treatment groups
Group A: SAPB GroupExperimental treatment 1 intervention
Group B: SPSIPB GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Pain Intensity

Postoperative pain intensity and time to first analgesic requirement will be evaluated. Pain will be assessed using the Numeric Rating Scale (NRS, 0-10) at 0 and 30 minutes, and at 1, 2, 4, 8, 12, 24, 36, and 48 hours postoperatively, both at rest and during movement, by a blinded investigator

Time frame
Within 48 hours postoperatively

Secondary outcomes

1

Total Analgesic Consumption

Total consumption of additional analgesics (paracetamol and opioid) will be recorded.

Time frame
Within 48 hours postoperatively
2

Additional Analgesic Requirement

The number of patients requiring additional analgesia and the frequency of administration will be recorded.

Time frame
Within 48 hours postoperatively
3

Intraoperative Opioid Consumption

The total amount of opioids administered intraoperatively will be recorded.

Time frame
During surgery
4

Intraoperative mean arterial pressure (mmHg)

Mean arterial pressure (mmHg) will be recorded at 30 minute intervals during surgery and summarized as mean values.

Time frame
Every 30 minutes intraoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.